ThirtyFiveBio Limited
ThirtyFiveBio | Home
United Kingdom · Founded 2021 · $20.0M raised
- Founded
- 2021
- Business Model
- B2B
- Website
- thirtyfivebio.com
- Total Funding
- $20.0M
- Last Round
- $20.0M BridgeApr 2025
- Rounds
- 2
About
Biotechnology company developing first-in-class small molecule GPR35 inhibitors to treat ulcerative colitis by protecting the gut epithelial barrier.
Summary
ThirtyFiveBio Limited is a Biotech company based in United Kingdom, founded in 2021. It has raised $20.0M in total across 2 rounds, most recently a $20.0M Bridge round in Apr 2025. Investors include AbbVie Ventures, M:M Bio and Canaan Partners.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Apr 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.